| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |